NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoffmann-La Roche
Fundación GECP